The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
We talk to Giffin Daughtridge, CEO of medical diagnostics company, UrSure, about treatment adherence and the impact of long-acting cabotegravir as injectable PrEP.
An Avert spotlight on the HIV response – we reflect on the most important take-homes from the UNAIDS 2019 Global Report.
A new agenda to advance sexual and reproductive health and rights (SRHR) presented by the Guttmacher–Lancet Commission has wide-ranging implications for the HIV response
New commitments are made at the Family Planning Summit to bolster access to modern contraceptives for the world’s poorest women – but is it enough to the bridge the gap?
The 90-90-90 Fast-Track targets is a hot-topic at this week’s 21st International AIDS Conference in Durban, South Africa (AIDS 2016). Progress towards the targets, which call for 90% of people living with HIV to know their status, 90% on HIV treatment, and 90% virally suppressed, is acheivable but success is not uniform.
Family planning is not only about the rights of women and girls to make their own choices about having children and looking after their reproductive health, it's also key to global development.